The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 94; no. 13
Main Authors Dutta, Noton K., Mazumdar, Kaushiki, Gordy, James T.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 16.06.2020
Subjects
Betacoronavirus
Coronavirus Infections
COVID-19
Humans
Letter to the Editor
Nucleocapsid Proteins
Pandemics
Pneumonia, Viral
SARS Virus
SARS-CoV-2
nucleocapsid protein
vaccine
severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2)
coronavirus disease 2019 (COVID-19)
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
Citation Dutta NK, Mazumdar K, Gordy JT. 2020. The nucleocapsid protein of SARS–CoV-2: a target for vaccine development. J Virol 94:e00647-20. https://doi.org/10.1128/JVI.00647-20.
ISSN:0022-538X
1098-5514
1098-5514
DOI:10.1128/JVI.00647-20